Unknown

Dataset Information

0

The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT.


ABSTRACT: Individual comorbidities have distinct contributions to nonrelapse mortality (NRM) following allogeneic hematopoietic cell transplantation (allo-HCT). We studied the impact of comorbidities individually and in combination in a single-center cohort of 573 adult patients who underwent CD34-selected allo-HCT following myeloablative conditioning. Pulmonary disease, moderate to severe hepatic comorbidity, cardiac disease of any type, and renal dysfunction were associated with increased NRM in multivariable Cox regression models. A Simplified Comorbidity Index (SCI) composed of the 4 comorbidities predictive of NRM, as well as age >60 years, stratified patients into 5 groups with a stepwise increase in NRM. NRM rates ranged from 11.4% to 49.9% by stratum, with adjusted hazard ratios of 1.84, 2.59, 3.57, and 5.38. The SCI was also applicable in an external cohort of 230 patients who underwent allo-HCT with unmanipulated grafts following intermediate-intensity conditioning. The area under the receiver operating characteristic curve (AUC) of the SCI for 1-year NRM was 70.3 and 72.0 over the development and external-validation cohorts, respectively; corresponding AUCs of the Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) were 61.7 and 65.7. In summary, a small set of comorbidities, aggregated into the SCI, is highly predictive of NRM. The new index stratifies patients into distinct risk groups, was validated in an external cohort, and provides higher discrimination than does the HCT-CI.

SUBMITTER: Shouval R 

PROVIDER: S-EPMC8905694 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT.

Shouval Roni R   Fein Joshua A JA   Cho Christina C   Avecilla Scott T ST   Ruiz Josel J   Tomas Ana Alarcon AA   Sanchez-Escamilla Miriam M   Flores Nerea Castillo NC   Yáñez Lucrecia L   Barker Juliet N JN   Dahi Parastoo P   Giralt Sergio A SA   Geyer Alexander I AI   Gyurkocza Boglarka B   Jakubowski Ann A AA   Lin Richard J RJ   O'Reilly Richard J RJ   Papadopoulos Esperanza B EB   Politikos Ioannis I   Ponce Doris M DM   Sauter Craig S CS   Scordo Michael M   Shaffer Brian B   Shah Gunjan L GL   Sullivan James P JP   Tamari Roni R   van den Brink Marcel R M MRM   Young James W JW   Nagler Arnon A   Devlin Sean S   Shimoni Avichai A   Perales Miguel-Angel MA  

Blood advances 20220301 5


Individual comorbidities have distinct contributions to nonrelapse mortality (NRM) following allogeneic hematopoietic cell transplantation (allo-HCT). We studied the impact of comorbidities individually and in combination in a single-center cohort of 573 adult patients who underwent CD34-selected allo-HCT following myeloablative conditioning. Pulmonary disease, moderate to severe hepatic comorbidity, cardiac disease of any type, and renal dysfunction were associated with increased NRM in multiva  ...[more]

Similar Datasets

| S-EPMC10843799 | biostudies-literature
| S-EPMC6957460 | biostudies-literature
| S-EPMC8267144 | biostudies-literature
| S-EPMC4432013 | biostudies-literature
| S-EPMC10961739 | biostudies-literature
| S-EPMC9536795 | biostudies-literature
| S-EPMC10228715 | biostudies-literature
| S-EPMC5894265 | biostudies-literature
| S-EPMC11780814 | biostudies-literature